Document:

Amendment No 5

Exhibit 4.6

CONSENT AGREEMENT AND
AMENDMENT NO. 5
TO LOAN AND SECURITY AGREEMENT

CONSENT AGREEMENT AND AMENDMENT NO. 5 TO LOAN AND SECURITY AGREEMENT, dated as of June 30, 2004 (this “Agreement”), to the Loan and Security Agreement referred to below by and among MATRIA HEALTHCARE, INC., a Delaware corporation (together with its permitted successors and assigns, the “Parent”), DIABETES ACQUISITION, INC., a Georgia corporation and wholly-owned subsidiary of the Parent (together with its permitted successors and assigns, “DAI”), GAINOR MEDICAL ACQUISITION COMPANY, a Georgia corporation and wholly-owned subsidiary of DAI (together with its permitted successors and assigns, “Gainor”), DIABETES MANAGEMENT SOLUTIONS, INC., a Delaware corporation and wholly-owned subsidiary of Gainor (together with its permitted successors and assigns, “DMS”), DIABETES SELF CARE, INC., a Virginia corporation and wholly-owned subsidiary of Gainor (together with its permitted successors and assigns, “DSC”), MATRIA LABORATORIES, INC., a Delaware corporation and wholly-owned subsidiary of DSC (together with its permitted successors and assigns, “MLI”), FACET TECHNOLOGIES, LLC, a Georgia limited liability company whose interests are wholly-owned by the Parent (together with its permitted successors and assigns, “Facet”), MATRIA OF NEW YORK, INC., a New York corporation and wholly-owned subsidiary of the Parent (together with its permitted successors and assigns, “MNY”), MATRIA HEALTHCARE OF ILLINOIS, INC., a Georgia corporation and wholly-owned subsidiary of the Parent (together with its permitted successors and assigns, “MII”), QUALITY ONCOLOGY, INC., a Delaware corporation and wholly-owned subsidiary of the Parent (together with its permitted successors and assigns, “QO”) (the Parent, DAI, Gainor, DMS, DSC, MLI, Facet, MNY, MII and QO, each individually a “Borrower” and jointly and severally, the “Borrowers”), MATRIA HEALTHCARE, INC., in its capacity as authorized representative of the Borrowers (the “Authorized Representative”), and HFG HEALTHCO-4, LLC, a Delaware limited liability company (together with its successors and assigns, the “Lender”).

W I T N E S S E T H

WHEREAS, the Borrowers, the Authorized Representative and the Lender are parties to that certain Loan and Security Agreement, dated as of October 22, 2002 (including all annexes, exhibits and schedules thereto, and as amended, restated, supplemented or otherwise modified from time to time, including, without limitation, by that certain Amendment No. 1 to Loan and Security Agreement dated as of December 31, 2002, that certain Amendment No. 2 to Loan and Security Agreement dated as of December 31, 2003, that certain Consent and Waiver Agreement and Amendment No. 3 to Loan and Security Agreement dated as of April 23, 2004, that certain Consent and Waiver Agreement and Amendment No.4 to Loan and Security Agreement dated as of April 29, 2004, and that certain Consent Agreement dated as of June 22, 2004, the “Loan and Security Agreement”);

 

WHEREAS, the Parent, DSC and DMS (DSC and DMS together, the “Seller”) and DEGC Enterprises (U.S.), INC., a Florida corporation (“DEGC”), are parties to that certain Asset Purchase Agreement dated June 22, 2004 (the “Asset Purchase Agreement”);

 

WHEREAS, the Parent, Seller and DEGC intend to consummate the transactions contemplated by the Asset Purchase Agreement; and

 

WHEREAS, the consummation of the transactions contemplated by the Asset Purchase Agreement would be in violation of the Loan and Security Agreement, and Lender has agreed to consent to the consummation of such transactions pursuant to the Asset Purchase Agreement on the terms and conditions provided for herein; 

 

NOW THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt, adequacy and sufficiency of which are hereby acknowledged, the Borrowers, the Authorized Representative and the Lender hereby agree as follows:

	
Definitions. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Loan and Security Agreement.

	
Consents. As of the Agreement Effective Date (as hereinafter defined), the Lender hereby consents, pursuant to Section 6.01 of the Loan and Security Agreement and notwithstanding anything set forth to the contrary in clauses (g), (r) and (z) of Exhibit IV and clauses (e), (m) and (v) of Exhibit V to the Loan and Security Agreement, to the Parent, DSC and DMS consummating the transactions contemplated by the Asset Purchase Agreement including, without limitation, the sale and purchase of the Assets. Notwithstanding the foregoing:

	
this consent shall not permit the Borrowers to (x) send a Revocation Order (as defined in the Depositary Agreements) or make any change or replacement in the Standing Revocable Instruction (as defined in the Depositary Agreements) or (y) fail to provide notice to any Lockbox Bank that the Lender shall have full control of any Lender Lockbox or Lender Lockbox Account promptly upon the written request of the Lender and in any event within two Business Days’ of such written request, in either case with respect to payments by Obligors on all or any portion of a Receivable;

	
the consent of the Lender to the consummation of any sale of the capital stock or assets of MLI pursuant to Section 7.14 of the Asset Purchase Agreement is made pursuant to the Borrowers’ agreement that at the time of, or prior to, such sale, the Borrowers will deliver to the Lender modifications to the Loan and Security Agreement and the other Documents in form and substance satisfactory to the Lender; and

	
this consent shall not permit the Borrowers to any Borrower to sell, lease, assign, transfer, or otherwise dispose of any of its Receivables or other Collateral, other than the Assets (as such term is defined in the Asset Purchase Agreement).

	
Waivers. Upon the Agreement Effective Date, the Lender hereby agrees to waive any Default or Event of Default arising pursuant to:

	
a breach of the covenant set forth in clause (f) of Exhibit IV of the Loan and Security Agreement, solely to the extent that such breach arises with respect to the preferential arrangements described in the Interim Management Services Agreement to be delivered pursuant to the terms of the Asset Purchase Agreement in the form of Exhibit E attached thereto or the sharing of agreements and other arrangements pursuant to the transfer of the Assets (as such term is defined in the Asset Purchase Agreement) as described in the Asset Purchase Agreement; or

	
the Borrowers’ payment of cash earnout payments to the QO Seller pursuant to Section 1.5 of the QO Acquisition Agreement with the proceeds of the transactions contemplated by the Asset Purchase Agreement in the absence of the certification required by clause (ee) of Exhibit V to the Loan and Security Agreement, provided that the Borrowers hereby represent and warrant that (x) such payment will not otherwise result in an Event of Default, and (y) the amount of such payment will not exceed the sum of (A) 75.0% of the average amount, calculated on a daily basis, of the Borrowers’ cash-in-hand during the prior 30 days and (B) the average amount, calculated on a daily basis, by which the Revolving Commitment exceeded the Revolving Loan during the prior 30 days.

	
Amendments. 

	
Exhibit I to the Agreement is amended by adding the following additional defined terms in the appropriate alphabetical order:

“Amendment No. 5” means that certain Consent Agreement and Amendment No. 5 to this Agreement, dated as of June 30, 2004.

“EBITDA Adjustment Limit” means (i) for the fiscal quarter ending September 30, 2004, $600,000, (ii) for the fiscal quarter ending December 31, 2004, $500,000, (iii) for the fiscal quarter ending March 31, 2005, $400,000, (iv) for the fiscal quarter ending June 30, 2005, $300,000, (v) for the fiscal quarter ending September 30, 2005, $200,000, and (vi) for the fiscal quarter ending December 31, 2005, $100,000. 

b.Exhibit I to the Loan and Security Agreement is further amended by amending and restating the definition of “EBITDA” in its entirety to read as follows:

   “EBITDA” of the Parent and its Subsidiaries means, for any period, the sum of (a) net income (or net loss)(calculated before extraordinary items), during such period plus (b) Interest Expense during such period deducted in the determination of such net income (or net loss), plus (c) depreciation, amortization and other non-cash items for such period to the extent included in the determination of net income (or net loss) plus or minus (d) all taxes accrued for such period on or measured by income to the extent deducted or credited in determining such net income (or net loss) minus or plus (e) gains (or losses) from asset dispositions outside of the normal course of business to the extent included in determining such net income (or net loss), plus (f) losses due to asset impairment plus (g) non-cash, non-recurring items to the extent included in determining such net income (or net loss); provided, that in calculating EBITDA for any period from the closing of the asset sale contemplated by the Asset Purchase Agreement (as such term is defined in Amendment No. 5 hereto) up to and including December 31, 2005, the EBITDA of DSC and DMS during any such period shall be excluded for such period up to a negative amount of EBITDA not to exceed the EBITDA Adjustment Limit.

c.Clause (p) of Exhibit V (Events of Default) to the Loan and Security Agreement is amended in its entirety to read as follows: 

(p)   The ratio of Debt to EBITDA for the immediately prior 12-month period for the Parent and its Subsidiaries for any Test Period is greater than 3.5:1.0. 

d.Clause (r) of Exhibit V (Events of Default) to the Loan and Security Agreement is amended in its entirety to read as follows: 

(r)   The Current Ratio as at the end of any fiscal quarter of the Parent and its Subsidiaries is less than 1.6:1.0.

	
Remedies. This Agreement shall constitute a Document. The breach by the Parent or any other Borrower of any representation, warranty, covenant or agreement in this Agreement shall constitute an immediate Event of Default hereunder and under the other Documents.

	
Representations and Warranties. To induce the Lender to enter into this Agreement, each Borrower, jointly and severally and giving effect to this Agreement, makes the following representations and warranties to the Lender:

	
The execution, delivery and performance by it of this Agreement and the performance of the Loan and Security Agreement, the Documents and the other documents to be delivered by it thereunder and the actions contemplated hereby and thereby, including, in the case of the Parent, DSC and DMS, the Asset Purchase Agreement, (i) are within its corporate or company powers, (ii) have been duly authorized by all necessary corporate or company action, (iii) do not contravene (1) its charter or its bylaws, or its operating agreement, as applicable, (2) any law, rule or regulation applicable to it, (3) the Indenture or any contractual restriction binding on or affecting it or its Property, or (4) any order, writ, judgment, award, injunction or decree binding on or affecting it or its Property, and (iv) do not result in or require the creation of any Lien upon or with respect to any of its Properties, other than the Loan and Security Agreement or the Documents. This Agreement has been duly executed and delivered by it. It has previously furnished to the Lender a true, correct and complete copy of its charter, bylaws or operating agreement, as applicable, including all amendments thereto.

	
This Agreement, the Loan and Security Agreement and the Documents constitute the legal, valid and binding obligation of the Borrowers, enforceable against the Borrowers in accordance with their respective terms, except as limited by bankruptcy, insolvency, moratorium, fraudulent conveyance or other laws relating to the enforcement of creditors’ rights generally and general principles of equity (regardless of whether enforcement is sought at equity or law).

	
No event has occurred and is continuing, or would result from the execution of this Agreement, that constitutes a Default or Event of Default.

	
Except as disclosed on Schedule III to the Loan and Security Agreement, there is no pending or, to its knowledge, threatened action or proceeding or injunction, writ or restraining order affecting it before any court, Governmental Entity or arbitrator which could reasonably be expected to result in a Material Adverse Effect, or which purports to affect the legality, validity or enforceability of this Agreement or the Loan and Security Agreement, or any other Document executed in connection herewith or therewith, and it is not currently the subject of, or has any present intention of commencing, an insolvency proceeding or petition in bankruptcy.

	
After giving effect to this Agreement, the representations and warranties of each Borrower contained in the Loan and Security Agreement and each other Document are true and correct on and as of the Agreement Effective Date with the same effect as if such representations and warranties had been made on and as of such date, except that any such representation or warranty which is expressly made only as of a specified date need be true only as of such date.

	
No Other Waivers or Consents. Except as expressly provided herein, the Loan and Security Agreement and the other Documents shall be unmodified and shall continue to be in full force and effect in accordance with their terms. In addition, except as specifically provided herein, this Agreement shall not be deemed a (i) waiver of any term or condition of any Document or (ii) consent to any deviation from the terms of the Loan and Security Agreement or any of the other Documents on the part of the Parent or any other Borrower, and shall not be deemed to prejudice any right or rights which the Lender may now have or may have in the future under or in connection with the Loan and Security Agreement or any other Document or any of the instruments or agreements referred to therein, as the same may be amended from time to time.

	
Expenses. Each Borrower hereby reconfirms its respective obligations pursuant to Section 6.05 of the Loan and Security Agreement to pay and reimburse the Lender for all reasonable costs and out-of-pocket expenses (including, without limitation, reasonable counsel fees and expenses) incurred in connection with the negotiation, preparation, execution and delivery of this Agreement and all other documents and instruments delivered in connection herewith.

	
Effectiveness. This Agreement shall become effective as of the date first set forth above (the “Agreement Effective Date”) only upon satisfaction in full in the judgment of the Lender of each of the following conditions:

	
Collection of Accounts Agreement. The Borrowers shall have delivered a fully-executed copy of that certain A/R Remittance and Product Return Agreement dated as of the date hereof by and among DEGC, the Parent, DSC and DMS in form and substance satisfactory to the Lender. 

	
Agreement. The Lender shall have received copies by facsimile of duly executed signature pages of this Agreement from each Borrower, the Authorized Representative and the Lender.

	
Representations and Warranties. The representations and warranties of or on behalf of the Borrowers in this Agreement shall be true and correct on and as of the Agreement Effective Date.

	
GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK WITHOUT REGARD TO ANY CONFLICTS OF LAWS PRINCIPLES THEREOF.

	
Counterparts. This Agreement may be executed by the parties hereto on any number of separate counterparts and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed counterpart of a signature page to this Agreement by telecopier or electronic mail shall be effective as delivery of a manually executed counterpart of this Agreement.

[SIGNATURE PAGE FOLLOWS]

 

 

	 
	 	 	 
	

	 

 

This letter shall be governed by the laws of the State of New York (without reference to conflicts of law).

	
 
	
 
	
HFG HEALTHCO-4 LLC

	
 
	
 
	
By: HFG HEALTHCO-4, INC., a member

	
 
	
 
	
 

	
Acknowledged and agreed as of
	
 
	
By: /s/

			

	
the date first written above:
	
 
	
Name: Mary L. Brady

	
 
	
 
	
Title: Vice President

	
DEGC ENTERPRISES (U.S.), INC.
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
 

	
By: /s/
	
 
	
 

	

		
	
Name: David L. Kosovich
	
 
	
 

	
Title:
	
 
	
 

	
 
	
 
	
 

	
MATRIA HEALTHCARE, INC.,
	
 
	
 

	
as Authorized Representative
	
 
	
 

	
 
	
 
	
 

	
By: /s/
	
 
	
 

	

		
	
Name: Parker H. Petit
	
 
	
 

	
Title: CEO
	
 
	
 

	
 
	
 
	
 

	
DIABETES MANAGEMENT SOLUTIONS, INC.
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
 

	
By: /s/
	
 
	
 

	

		
	
Name: Yvonne V. Scoggins
	
 
	
 

	
Title: Treasurer
	
 
	
 

	
 
	
 
	
 

	
DIABETES SELF CARE, INC.
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
 

	
By: /s/
	
 
	
 

	

		
	
Name: Yvonne V. Scoggins
	
 
	
 

	
Title: TreasurerSupplemental Indenture April 19 2004

Exhibit 4.2

SUPPLEMENTAL INDENTURE

THIS SUPPLEMENTAL INDENTURE (the “Supplemental Indenture”) is executed as of this 19th day of April, 2004, by Matria Healthcare, Inc. (“Matria”) and Wells Fargo Bank, N.A., as Trustee under the indenture referenced below (the “Trustee”).

WHEREAS, Matria, as issuer, and certain of its wholly-owned subsidiaries (the “Guarantors”) have heretofore entered into an Indenture, dated as of July 9, 2001 (the “Indenture”), with the Trustee pursuant to which the Trustee acts as trustee for the Holders of Matria’s 11% Senior Notes due 2008 (including Matria’s 11% Series B Senior Notes due 2008, the “Notes”);

WHEREAS, Section 8.02 of the Indenture provides that Matria and the Trustee may amend or supplement the Indenture or the Notes with the consent of the Holders of a majority in aggregate principal amount of the Notes then outstanding, subject to certain conditions contained therein;

WHEREAS, pursuant to the Offer to Purchase and Consent and Waiver Solicitation Statement dated March 29, 2004 (the “Statement”), Matria has commenced an offer to purchase any and all of the outstanding Notes (the “Tender Offer”) and a solicitation to obtain the consent of not less than a majority in aggregate principal amount of the Notes (the “Consent Solicitation”) to certain proposed amendments (the “Proposed Amendments”) to the Indenture;

WHEREAS, the Holders of at least a majority in aggregate principal amount of the Notes outstanding as of April 14, 2004 have tendered their Notes for purchase by Matria in connection with the Tender Offer and consented to the Proposed Amendments as described in this Supplemental Indenture; and 

WHEREAS, pursuant to Section 8.02 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

NOW THEREFORE, in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto agree as follows.

1.   Capitalized Terms. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

2.   Amendments to the Indenture. 

a.   The Indenture is hereby amended by deleting Sections 4.02, 4.06, 4.07, 4.08, 4.09, 4.10, 4.11, 4.12, 4.13, 4.14, 4.15, 4.16, 4.17, 4.18, 4.21, 4.22, 5.01(3), 6.01(5), and 6.01(6) of the Indenture and replacing them with the words “Intentionally Omitted” and by deleting all references to such sections in their entirety, including without limitation, all references direct or indirect thereto in Section 6.01 “Events of Default.” 

b.   Exhibit A, Form of Reverse of Notes, of the Indenture is hereby amended by deleting Section 13 in its entirety and replacing it with the following:

   “Restrictive Covenants. The Indenture imposes certain limitations on the ability of the Company and its Restricted Subsidiaries to, among other things, merge or consolidate with any other Person or transfer all or substantially all of the Company’s or any Guarantor’s assets. Such limitations are subject to a number of important qualifications and exceptions. Pursuant to Section 4.04 of the Indenture, the Company must annually report to the Trustee on compliance with such limitations.”

3.   Related Definitions and References. Pursuant to the Proposed Amendments, all definitions used exclusively in, and all references to, the deleted sections of the Indenture set forth in Section 2 above are also deleted in their entirety, unless otherwise specified.

4.   Notification to Holders. Matria shall notify the Holders in accordance with Section 8.02 of the Indenture of the effectiveness of this Supplemental Indenture. Any failure of Matria to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of this Supplemental Indenture.

5.   Receipt by Trustee. In accordance with Section 8.02 of the Indenture, the Trustee acknowledges that it has received a copy of the resolutions of Matria’s Board of Directors authorizing the execution of this Supplemental Indenture and satisfactory evidence of the consent of the Holders of the Notes to the execution of this Supplemental Indenture. In addition, in accordance with Section 11.04 and Section 11.05 of the Indenture, the Trustee acknowledges that its has received an Officers’ Certificate and Opinion of Counsel stating that the execution of this Supplemental Indenture is permitted by the Indenture and all conditions precedent and covenants relating to the execution of this Supplemental Indenture have been satisfied.

6.   Parties. Nothing expressed or mentioned herein is intended or shall be construed to give any Person other than the Holders and the Trustee, any legal or equitable right, remedy or claim under or in respect of this Supplemental Indenture or the Indenture or any provision herein or therein contained.

7.   Governing Law. This Supplemental Indenture shall be governed by and construed in accordance with the laws of the State of New York, as applied to contracts made and performed in the state of New York.

8.   Separability. Each provision of this Supplemental Indenture shall be considered separable and if for any reason any provision which is not essential to the effectuation of the basic purpose of this Supplemental Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

9.   Condition to Operative Effect. For purposes of Section 8.02 of the Indenture only, this Supplemental Indenture shall become effective upon execution hereof by the Trustee, Matria and the Guarantors. For all other purposes, including Section 2 hereof, this Supplemental Indenture shall not become operative until the opening of business on the day on which Matria gives oral notice (confirmed in writing) or written notice to the Trustee, as depositary, that all conditions to the Tender Offer have either been satisfied or, other than the Financing Condition (as defined in the Statement), waived and the Notes tendered by the Holders pursuant to the Tender Offer have been accepted for payment and the Tender Offer and Consent Solicitation is closed. Notwithstanding the foregoing, and irrespective of whether the Tender Offer is completed, the Supplemental Indenture will not become operative if the Financing Condition is not satisfied.

10.   Multiple Counterparts. The parties may sign multiple counterparts of this Indenture. Each signed counterpart shall be deemed an original, but all of them together represent one and the same agreement.

11.   Effect of Headings. The headings of the sections in this Supplemental Indenture have been inserted for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.

12.   The Trustee. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity, legality or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by Matria.

13.   Ratification of Indenture; Supplemental Indenture Part of Indenture. Except as expressly supplemented hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of the Indenture for all purposes, and every Holder of Notes heretofore or hereafter authenticated and delivered shall be bound hereby.

[Signatures follow on next page]

 

	 
	 	 	 
	

	 

 

	
 
	
 

	
 
	
MATRIA HEALTHCARE, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Parker H. Petit

	
 
	
Chairman and Chief Executive Officer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Roberta L. McCaw

	
 
	
Title:

	
 
	
 

	
 
	
CLINICAL-MANAGEMENT SYSTEMS, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Parker H. Petit

	
 
	
Title: President

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
DIABETES ACQUISITION, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Treasurer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
DIABETES MANAGEMENT SOLUTIONS, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Treasurer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
DIABETES SELF CARE, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Treasurer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
FACET TECHNOLOGIES, L.L.C

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Treasurer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
GAINOR MEDICAL ACQUISITION COMPANY

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Treasurer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
 

	
 
	
GAINOR MEDICAL INTERNATIONAL, L.L.C.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Treasurer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
GAINOR MEDICAL DIRECT, L.L.C.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Treasurer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
INFERTILITY MANAGEMENT SERVICES, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Treasurer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
MARKETRING.COM, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Parker H. Petit

	
 
	
Title: Vice President

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Treasurer

	
 
	
 

	
 
	
MATRIA LABORATORIES, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Vice President and Treasurer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
MATRIA OF NEW YORK, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Yvonne V. Scoggins

	
 
	
Title: Treasurer

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
PFCC LIQUIDATION CORP.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Parker H. Petit

	
 
	
Title: President

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
PFPC LIQUIDATION CORP.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Parker H. Petit

	
 
	
Title: President

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
PFMG LIQUIDATION CORP.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Parker H. Petit

	
 
	
Title: President

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name: Roberta L. McCaw

	
 
	
Title: Secretary

	
 
	
 

	
 
	
NATIONAL REPRODUCTIVE MEDICAL CENTERS, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Parker H. Petit

	
 
	
President

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Roberta L. McCaw

	
 
	
Secretary

	
 
	
 

	
 
	
Q LIQUIDATION CORP.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Parker H. Petit

	
 
	
President

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Roberta L. McCaw

	
 
	
Secretary

	
 
	
 

	
 
	
QUALITY ONCOLOGY, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Parker H. Petit

	
 
	
Chairman

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Roberta L. McCaw

	
 
	
Vice President and Secretary

	
 
	
 

	
 
	
SHARED CARE, INC.

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Parker H. Petit

	
 
	
President

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Roberta L. McCaw

	
 
	
Secretary

	
 
	
 

	
 
	
WELLS FARGO BANK, N.A., as Trustee

	
 
	
 

	
 
	
By: /s/

		

	
 
	
Name:

	
 
	
Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}]]